BIO-TECHNE Corp (TECH) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
60/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinTECH / S&P 35.44% / 15.20% |
LoseTECH / S&P -0.38% / 15.00% |
WinTECH / S&P 150.00% / 50.40% |
| 2026-Q10/3 |
LoseTECH / S&P -11.02% / -4.33% |
LoseTECH / S&P 0.17% / 11.30% |
LoseTECH / S&P -16.87% / 27.70% |
| 2025-Q41/3 |
WinTECH / S&P 5.86% / 2.65% |
LoseTECH / S&P 1.64% / 9.00% |
LoseTECH / S&P -49.00% / 13.40% |
| 2025-Q31/3 |
WinTECH / S&P 8.29% / 8.12% |
LoseTECH / S&P 3.85% / 4.61% |
LoseTECH / S&P -48.42% / 13.45% |
| 2025-Q21/3 |
LoseTECH / S&P -12.10% / 10.94% |
WinTECH / S&P 5.23% / 4.83% |
LoseTECH / S&P -56.19% / 10.63% |
| 2025-Q10/3 |
LoseTECH / S&P -18.51% / -4.27% |
LoseTECH / S&P 4.72% / 4.98% |
LoseTECH / S&P -33.60% / 10.57% |
| 2024-Q40/3 |
LoseTECH / S&P -9.79% / 2.41% |
LoseTECH / S&P 4.46% / 5.25% |
LoseTECH / S&P -27.01% / 6.15% |
| 2024-Q31/3 |
WinTECH / S&P 11.68% / 5.89% |
LoseTECH / S&P 2.41% / 5.89% |
LoseTECH / S&P -37.09% / 6.11% |
| 2024-Q20/3 |
LoseTECH / S&P 1.89% / 4.28% |
LoseTECH / S&P 1.97% / 5.38% |
LoseTECH / S&P -40.00% / 5.12% |
| 2024-Q10/3 |
LoseTECH / S&P -8.67% / 10.56% |
LoseTECH / S&P 2.73% / 5.71% |
LoseTECH / S&P -25.15% / 5.59% |
| 2023-Q41/3 |
WinTECH / S&P 13.51% / 11.69% |
LoseTECH / S&P 2.25% / 6.81% |
LoseTECH / S&P -14.91% / 7.78% |
| 2023-Q30/3 |
LoseTECH / S&P -16.53% / -3.27% |
LoseTECH / S&P 2.37% / 7.52% |
LoseTECH / S&P -15.64% / -5.03% |
| 2023-Q21/3 |
WinTECH / S&P 10.14% / 8.74% |
LoseTECH / S&P 2.81% / 9.50% |
LoseTECH / S&P -40.27% / -8.57% |
| 2023-Q11/3 |
LoseTECH / S&P -10.39% / 7.50% |
LoseTECH / S&P 4.39% / 10.77% |
WinTECH / S&P 438.71% / -15.69% |
| 2022-Q42/3 |
WinTECH / S&P 16.85% / 7.56% |
LoseTECH / S&P 8.77% / 11.88% |
WinTECH / S&P 51.89% / -17.99% |
| 2022-Q32/3 |
LoseTECH / S&P -18.00% / -4.88% |
WinTECH / S&P 13.51% / 13.47% |
WinTECH / S&P 4.07% / -1.41% |
| 2022-Q22/3 |
LoseTECH / S&P -19.88% / -16.10% |
WinTECH / S&P 18.75% / 13.71% |
WinTECH / S&P 240.70% / 11.04% |
| 2022-Q11/3 |
LoseTECH / S&P -16.23% / -4.60% |
WinTECH / S&P 26.96% / 15.97% |
LoseTECH / S&P -93.25% / 42.23% |
| 2021-Q41/3 |
LoseTECH / S&P 6.83% / 11.03% |
WinTECH / S&P 28.86% / 15.00% |
LoseTECH / S&P -75.85% / 96.40% |
| 2021-Q32/3 |
WinTECH / S&P 7.69% / 0.58% |
WinTECH / S&P 29.61% / 10.77% |
LoseTECH / S&P -72.52% / 69.42% |
| 2021-Q22/3 |
WinTECH / S&P 17.99% / 8.55% |
WinTECH / S&P 26.04% / 6.58% |
LoseTECH / S&P -85.17% / 51.81% |
| 2021-Q12/3 |
WinTECH / S&P 20.37% / 6.17% |
WinTECH / S&P 12.37% / -1.06% |
LoseTECH / S&P -2.96% / 7.39% |
| 2020-Q43/3 |
WinTECH / S&P 28.32% / 12.15% |
WinTECH / S&P 7.29% / -3.72% |
WinTECH / S&P -11.49% / -33.42% |
| 2020-Q32/3 |
LoseTECH / S&P -6.07% / 8.93% |
WinTECH / S&P 3.45% / -2.04% |
WinTECH / S&P 161.92% / -27.10% |
| 2020-Q23/3 |
WinTECH / S&P 39.43% / 20.54% |
WinTECH / S&P 3.46% / -0.46% |
WinTECH / S&P 134.82% / -27.11% |
| 2020-Q13/3 |
WinTECH / S&P -13.48% / -19.60% |
WinTECH / S&P 7.39% / 3.47% |
WinTECH / S&P 50.64% / -14.75% |
| 2019-Q43/3 |
WinTECH / S&P 12.36% / 9.07% |
WinTECH / S&P 9.24% / 5.36% |
WinTECH / S&P 97.61% / 2.99% |
| 2019-Q31/3 |
LoseTECH / S&P -5.99% / 1.70% |
WinTECH / S&P 11.03% / 5.02% |
LoseTECH / S&P -28.66% / 0.21% |
| 2019-Q22/3 |
WinTECH / S&P 5.17% / 4.30% |
WinTECH / S&P 11.04% / 6.64% |
LoseTECH / S&P -25.60% / 8.65% |
| 2019-Q12/3 |
WinTECH / S&P 37.43% / 13.65% |
WinTECH / S&P 13.45% / 8.12% |
LoseTECH / S&P 5.72% / 14.29% |
| 2018-Q41/3 |
LoseTECH / S&P -28.97% / -13.52% |
WinTECH / S&P 13.74% / 9.05% |
LoseTECH / S&P -17.43% / 18.23% |
| 2018-Q33/3 |
WinTECH / S&P 38.20% / 7.71% |
WinTECH / S&P 14.61% / 10.21% |
WinTECH / S&P 71.79% / 19.06% |
| 2018-Q22/3 |
LoseTECH / S&P -1.84% / 3.43% |
WinTECH / S&P 14.21% / 9.03% |
WinTECH / S&P 63.55% / 14.46% |
| 2018-Q13/3 |
WinTECH / S&P 16.85% / -0.76% |
WinTECH / S&P 14.44% / 7.68% |
WinTECH / S&P 50.00% / 12.46% |
| 2017-Q43/3 |
WinTECH / S&P 7.43% / 6.64% |
WinTECH / S&P 13.49% / 7.03% |
WinTECH / S&P 38.18% / 13.82% |
| 2017-Q31/3 |
LoseTECH / S&P 3.17% / 4.48% |
WinTECH / S&P 11.56% / 5.68% |
LoseTECH / S&P -27.51% / 17.57% |
| 2017-Q22/3 |
WinTECH / S&P 15.93% / 3.09% |
WinTECH / S&P 12.82% / 4.83% |
LoseTECH / S&P -27.50% / 17.74% |
| 2017-Q11/3 |
LoseTECH / S&P -0.84% / 6.07% |
WinTECH / S&P 12.30% / 3.67% |
LoseTECH / S&P -29.54% / 13.32% |
| 2016-Q41/3 |
LoseTECH / S&P -5.79% / 3.82% |
WinTECH / S&P 13.55% / 2.09% |
LoseTECH / S&P -16.98% / 7.05% |
| 2016-Q31/3 |
LoseTECH / S&P -2.60% / 3.85% |
WinTECH / S&P 13.39% / 0.20% |
LoseTECH / S&P -5.61% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TECH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 33.41% | 20.78% |
| Annualized return | 33.41% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TECH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -41.31% | 83.14% |
| Annualized return | -10.11% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | TECH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 188.67% | 319.30% |
| Annualized return | 11.18% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |